
Erlotib 100mg Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Erlotinib (100mg)
Overview Erlotib 100mg Tablet
Erlotinib 100mg tablets treat non-small cell lung and pancreatic cancers. Administer this medication on an empty stomach, or at least one hour before or two hours after eating. Continue treatment as directed by your physician; duration is individualized. Follow your doctor's instructions precisely; incorrect usage or overdose can have severe consequences. Benefits may take weeks or months to appear; don't discontinue unless instructed. Common side effects include nausea, vomiting, tiredness, skin rash, and weight loss. Severe diarrhea requires increased fluid intake or medical attention. Photosensitivity is possible; use sun protection. Report mouth sores, vision changes, or breathing problems immediately. Liver function monitoring may be necessary. Inform your healthcare provider of all other medications you're taking, as interactions are possible. Avoid use during pregnancy or breastfeeding; reliable contraception is crucial for both partners. Smoking cessation is recommended during treatment to optimize efficacy. Separate antacid or other medication intake by at least two hours.
Primary Ingredients of Erlotib 100mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Erlotib 100mg Tablet
Cancers of the pancreas and non-small cell lung
Major Benefits of Erlotib 100mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Erlotib 100mg Tablet should be taken on an empty stomach.
Common Side effects of Erlotib 100mg Tablet:
- Abdominal pain
- Bone pain
- Breathlessness
- Constipation
- Cough
- Diarrhea
- Fatigue
- Fever
- Infection
- Muscle pain
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
How to use Erlotib 100mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 100mg Erlotib tablet should be taken on an empty stomach.
How Erlotib 100mg Tablet works:
Tarceva 100mg tablets are a cancer treatment. Lung cancer cells display epidermal growth factor receptors (EGFRs) on their surface, regulating their proliferation. The drug functions by attaching to EGFR, thus blocking the cancer-promoting signals these receptors transmit, thereby limiting tumor expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erlotib 100mg Tablet has an unknown safety profile. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Erlotib 100mg tablets is contraindicated during pregnancy due to established risks to fetal development. Exceptions may be made in life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Erlotib 100mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Erlotinib 100mg Tablet on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Erlotib 100mg tablets are considered safe, requiring no dosage modification. However, Erlotib 100mg tablets are unsuitable for individuals with severely impaired kidney function.
LiverCAUTION
Patients with liver impairment should use Erlotib 100mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Erlotib 100mg Tablet :
Omit any missed Erlotib 100mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Erlotib 100mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
